Johnson & Johnson Vision Care, Inc.
$6.8M 29,358 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Aptis Medical, LLC
Aptis Medical, LLC reported $6,787,708.08 across General Payments, Research, and Ownership to 95 physicians and teaching hospitals across 98 transactions.
- $6.8M
- All-tracks total
- 98
- Transactions
- 95
- Recipients
- +$849.0K
- General Payments vs PY2023
Aptis Medical, LLC reported $6,787,708.08 across all CMS Open Payments tracks (General + Research + Ownership) to 95 physicians and teaching hospitals in Program Year 2024 - ranking #226 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,198,862.47, averaging $71.4K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer aptis-medical-llc Aptis Medical, LLC
$6.8M · #226/1,925 · 0.0% industry · PY2024
- TOT $6.8M
- RANK #226
- SHARE 0.0%
- TXN 98
- RCP 95
- CAT 4
- GEN $1.2M
- ΔGEN +$849.0K
- TOP1 99.6%
- PY 2024
Volume peers
Nearest volume peer: Johnson & Johnson Vision Care, Inc. ($6.8M)
Aptis Medical, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Aptis Medical, LLC's CMS-reported General Payments increased by $849.0K (+242.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: APTIS MEDICAL, LLCPY2023: APTIS MEDICAL, LLCPY2024: Aptis Medical, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $349,910.97
- PY2024
- $1,198,862.47
What the Data Shows for Aptis Medical, LLC
In Program Year 2024, Aptis Medical, LLC reported $6,787,708.08 in payments to 95 physicians and teaching hospitals across 98 individual transactions, an average of $69.3K per transaction and $71.4K per recipient. That total places Aptis Medical, LLC at rank #226 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Royalty or License" leads the 4-category general-payment breakdown below at $948.2K (79.1% of General Payments, 4 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Aptis Medical, LLC made 4 types of general payments. "Royalty or License" is the largest category at $948.2K, 79.1% of General Payments.
Aptis Medical, LLC reports 4 general-payment categories - the top three are Royalty or License (79.1%), Consulting Fee (15.3%), and Travel and Lodging (4.0%). The remaining 1 category make up 1.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Aptis Medical, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $948.2K | 4 | 79.1% |
| Consulting Fee | $183.5K | 14 | 15.3% |
| Travel and Lodging | $48.5K | 55 | 4.0% |
| Food and Beverage | $18.6K | 22 | 1.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,198,862.47 (100.0%) of $1,198,862.47 in this company's General Payments records across 4 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Aptis Medical, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Luis Scheker
$1,193,816.79 across 89 reported transactions
- 2
Paul Sibley
$4,367.68 across 3 reported transactions
- 3
Alexander Shin
$501.00 across 2 reported transactions
- 4
Miguel Pirela-Cruz
$177.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Aptis Medical, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Aptis Medical, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Aptis Medical, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Astellas US Technologies
$6.9M 0 recipients
Compare payment profiles
GLW, Inc
$6.7M 11 recipients
Compare payment profiles
Astellas Pharma Inc
$6.9M 81 recipients
Compare payment profiles
Dompe Farmaceutici S.p.A.
$6.9M 7 recipients
Compare payment profiles
Arcutis Biotherapeutics, Inc.
$6.6M 47,756 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.